Marcin Michalak
About
In The Last Decade
Marcin Michalak
41 papers receiving 375 citations
Peers
Comparison fields: 5 of 57
- Cardiology and Cardiovascular Medicine 167
- Molecular Biology 111
- Immunology 59
- Cancer Research 48
- Public Health, Environmental and Occupational Health 47
Countries citing papers authored by Marcin Michalak
This map shows the geographic impact of Marcin Michalak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Michalak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Michalak more than expected).
Fields of papers citing papers by Marcin Michalak
This network shows the impact of papers produced by Marcin Michalak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Michalak. The network helps show where Marcin Michalak may publish in the future.
Co-authorship network of co-authors of Marcin Michalak
This figure shows the co-authorship network connecting the top 25 collaborators of Marcin Michalak. A scholar is included among the top collaborators of Marcin Michalak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcin Michalak. Marcin Michalak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | 0 | |
| 10 | 7 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | 2 | |
| 15 | 2 | |
| 16 | 4 | |
| 17 | 66 | |
| 18 | Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients. | 5 |
| 19 | Prediction value of serum Ca 125 level in benefit secondary cytoreduction in advanced ovarian cancer patients | 2 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.